Medicalgorithmics S.A. (MDG.WA)
PLN 17.1
(3.89%)
PLN 17.1
(3.89%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 433 Thousand PLN | -97.48% |
| 2022 | 17.21 Million PLN | 491.09% |
| 2021 | -4.4 Million PLN | 87.21% |
| 2020 | -34.4 Million PLN | -23461.64% |
| 2019 | -146 Thousand PLN | -100.59% |
| 2018 | 24.72 Million PLN | -40.88% |
| 2017 | 41.82 Million PLN | -10.12% |
| 2016 | 46.53 Million PLN | 120.24% |
| 2015 | 21.12 Million PLN | 52.08% |
| 2014 | 13.89 Million PLN | 38.84% |
| 2013 | 10 Million PLN | 41.5% |
| 2012 | 7.07 Million PLN | 129.01% |
| 2011 | 3.08 Million PLN | 45.9% |
| 2010 | 2.11 Million PLN | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -5.12 Million PLN | -11.42% |
| 2024 Q1 | -4.59 Million PLN | -947.38% |
| 2023 Q4 | -439 Thousand PLN | 7.38% |
| 2023 Q2 | -552 Thousand PLN | -125.27% |
| 2023 Q1 | 2.18 Million PLN | -60.72% |
| 2023 Q3 | -474 Thousand PLN | 14.13% |
| 2023 FY | 433 Thousand PLN | -97.48% |
| 2022 Q3 | 6.73 Million PLN | -24.56% |
| 2022 Q1 | -11.94 Million PLN | 92.15% |
| 2022 FY | 17.21 Million PLN | 491.09% |
| 2022 Q4 | 5.56 Million PLN | -17.38% |
| 2022 Q2 | 8.92 Million PLN | 174.7% |
| 2021 Q3 | -5.9 Million PLN | -67.47% |
| 2021 Q2 | -3.52 Million PLN | 30.78% |
| 2021 Q1 | -5.09 Million PLN | 58.48% |
| 2021 FY | -4.4 Million PLN | 87.21% |
| 2021 Q4 | -152.18 Million PLN | -2477.26% |
| 2020 FY | -34.4 Million PLN | -23461.64% |
| 2020 Q3 | -10.48 Million PLN | -70.68% |
| 2020 Q1 | -8.61 Million PLN | -60.75% |
| 2020 Q4 | -12.27 Million PLN | -17.08% |
| 2020 Q2 | -6.14 Million PLN | 28.75% |
| 2019 Q3 | -2.33 Million PLN | -272.42% |
| 2019 Q4 | -5.36 Million PLN | -129.3% |
| 2019 FY | -146 Thousand PLN | -100.59% |
| 2019 Q1 | 6.25 Million PLN | -39.8% |
| 2019 Q2 | 1.35 Million PLN | -78.34% |
| 2018 Q1 | 7.07 Million PLN | -29.01% |
| 2018 FY | 24.72 Million PLN | -40.88% |
| 2018 Q4 | 10.39 Million PLN | 198.59% |
| 2018 Q3 | 3.48 Million PLN | -7.69% |
| 2018 Q2 | 3.77 Million PLN | -46.67% |
| 2017 Q4 | 9.96 Million PLN | -29.31% |
| 2017 Q1 | 1.29 Million PLN | -95.89% |
| 2017 FY | 41.82 Million PLN | -10.12% |
| 2017 Q2 | 16.47 Million PLN | 1172.8% |
| 2017 Q3 | 14.09 Million PLN | -14.43% |
| 2016 Q3 | 8.87 Million PLN | -27.84% |
| 2016 FY | 46.53 Million PLN | 120.24% |
| 2016 Q4 | 31.47 Million PLN | 254.43% |
| 2016 Q1 | -6.12 Million PLN | -194.6% |
| 2016 Q2 | 12.3 Million PLN | 300.78% |
| 2015 FY | 21.12 Million PLN | 52.08% |
| 2015 Q1 | 4.67 Million PLN | 103.25% |
| 2015 Q4 | 6.47 Million PLN | 71.57% |
| 2015 Q3 | 3.77 Million PLN | -39.12% |
| 2015 Q2 | 6.2 Million PLN | 32.81% |
| 2014 Q1 | 3.76 Million PLN | 27.92% |
| 2014 Q2 | 3.96 Million PLN | 5.25% |
| 2014 Q3 | 3.88 Million PLN | -1.96% |
| 2014 Q4 | 2.29 Million PLN | -40.87% |
| 2014 FY | 13.89 Million PLN | 38.84% |
| 2013 Q3 | 2.71 Million PLN | 18.6% |
| 2013 FY | 10 Million PLN | 41.5% |
| 2013 Q2 | 2.28 Million PLN | 11.04% |
| 2013 Q1 | 2.06 Million PLN | 6.09% |
| 2013 Q4 | 2.94 Million PLN | 8.49% |
| 2012 Q4 | 1.94 Million PLN | 6.1% |
| 2012 Q1 | 1.65 Million PLN | 0.0% |
| 2012 FY | 7.07 Million PLN | 129.01% |
| 2012 Q2 | 1.64 Million PLN | -0.17% |
| 2012 Q3 | 1.83 Million PLN | 11.09% |
| 2011 FY | 3.08 Million PLN | 45.9% |
| 2010 FY | 2.11 Million PLN | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Adiuvo Investments S.A. | -5.07 Million PLN | 108.537% |
| Genomtec S.A. | -8.72 Million PLN | 104.962% |
| Medinice S.A. | -5.77 Million PLN | 107.493% |
| Synektik Spólka Akcyjna | 107.81 Million PLN | 99.598% |